Exenatide (exendin-4) is a licensed and effective treatment for patients with type 2 diabetes mellitus (T2DM).5 It is an agonist for the glucagon-like peptide 1 (GLP-1) receptor and in the presence of elevated blood glucose stimulates insulin release. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.